project id: TCGA-ESCA; case submitter id: TCGA-R6-A6Y0; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.54; rna integrity number: 8.2; age at index: 54; days to birth: -20045; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1951; age at diagnosis: 20045; ajcc clinical m: M1a; ajcc clinical n: N1; ajcc clinical stage: Stage IVA; ajcc clinical t: T3; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1641.0; icd 10 code: C15.5; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower third of esophagus; synchronous malignancy: No; tissue or organ of origin: Lower third of esophagus; tumor grade: Not Reported; year of diagnosis: 2005; treatment or therapy: no; alcohol history: Yes; is ffpe: false; weight: 5.0; composition: Not Reported; days to collection: 2867; days to sample procurement: 0; initial weight: 5.0; sample id: c2f4de31-1202-4cf5-89db-32f0900f75e8; sample submitter id: TCGA-R6-A6Y0-01B; portion id: dd89b108-2406-4664-8240-301aadfad3a0; portion submitter id: TCGA-R6-A6Y0-01B-11; slide id: e5dc2fd6-f518-4aeb-bf97-bf018f0f6b28; slide submitter id: TCGA-R6-A6Y0-01Z-00-DX1; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 6.0; percent necrosis: 0.0; percent neutrophil infiltration: 2.0; percent normal cells: 2.0; percent stromal cells: 13.0; percent tumor cells: 85.0; percent tumor nuclei: 90.0; section location: TOP;